Insider holders · CIK 0000822411
ImmunoCellular Therapeutics, Ltd. · IMUC
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Anthony GringeriSenior VP Strategic Resources | 150,000 | 66,000 | 216,000 | Mar 15, 2016 · 3:56 pm EDT | Form 4 |
| John S YuDirector | 120,250 | 258 | 120,508 | Jun 8, 2018 · 4:07 pm EDT | Form 4 |
| David FractorVP of Finance | 70,000 | 41,667 | 111,667 | Mar 15, 2016 · 3:59 pm EDT | Form 4 |
| Gary TitusDirector | 28,000 | — | 28,000 | Sep 22, 2015 · 4:58 pm EDT | Form 4 |
| Steven J SwansonSenior Vice President, Researc | 25,000 | — | 25,000 | Mar 15, 2016 · 4:00 pm EDT | Form 4 |
| Rahul SinghviDirector | 15,000 | — | 15,000 | Sep 22, 2015 · 4:54 pm EDT | Form 4 |
| Andrew GengosDirector | 5,249 | 1,175 | 6,424 | Feb 13, 2017 · 4:04 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.